Understand what your gut health results really mean
See your biomarkers in context with a comprehensive panel.
- CLIA-certified labs
- HIPAA compliant
- Personalized health protocol
Mapping Malassezia in your gut mycobiome
A malassezia test, in a gut context, detects this lipid-loving yeast as part of the fungal community of your gut microbiome, often called the mycobiome. Using a stool sample, labs identify Malassezia species and their relative amounts with DNA-based methods such as ITS rDNA profiling or metagenomic sequencing. Molecular approaches provide higher sensitivity and a clearer picture of which species are present and how abundant they are compared with a reference population. Results reflect the current state of your gut ecosystem rather than a fixed trait.
Why this matters: Malassezia is best known as a normal resident of human skin, but it is also detected in the gut, where it forms part of the smaller fungal community living alongside bacteria. In balanced amounts, gut fungi coexist peacefully with the rest of the microbiome. Shifts toward higher fungal load or lower diversity have been associated with digestive symptoms and altered immune signaling in the gut, and Malassezia in particular has been studied in relation to intestinal inflammation in research models. Mapping its presence connects the fungal side of your microbiome to the broader ecosystem picture.
What the fungal reading adds in real life
Testing makes the fungal side of the gut visible. If you have persistent digestive symptoms that haven't lined up with bacterial findings alone, a look at Malassezia and the wider mycobiome can add context -- whether the fungal community has expanded, lost diversity, or shifted in composition. It also helps clarify the impact of life details that move the gut ecosystem, such as recent antibiotics, a major diet change, or a stretch of high stress.
Zooming out, the bacterial and fungal sides of the gut shape each other, and both feed into barrier function, immune tone, and metabolism. Repeating measurements over time can track how interventions -- fiber diversity, fermented foods, sleep, and stress management -- influence the fungal balance. The goal isn't zero yeast; it's a resilient, well-balanced microbiome where fungi and bacteria coexist. Results are most useful interpreted with your history and, when needed, your clinician.
Test 100+ biomarkers
One blood draw. A full picture of your health, explained in plain language.
Test 100+ biomarkers
One blood draw. A full picture of your health, explained in plain language.
Reading a Malassezia report
Your report typically shows which Malassezia species are present and their relative abundance compared with a reference population, sometimes alongside overall mycobiome diversity. In general, balanced gut ecosystems show a modest fungal presence coexisting with a diverse bacterial community.
When results suggest balance, that usually aligns with comfortable digestion and calmer local immune signaling. “Optimal” isn't one number -- normal ranges vary with age, diet, geography, and recent exposures, so the result is best read as a snapshot within a broader ecosystem.
When results show higher Malassezia load or a fungal community dominated by a single species, that pattern doesn't diagnose a condition by itself; it highlights a biological pathway worth addressing. It is associated with reduced microbial balance and can accompany digestive symptoms, making it a useful flag to explore alongside other gut data.
Companion data that sharpen the picture
Malassezia data are most powerful alongside other gut readouts -- overall microbial diversity, organism-level results for yeasts such as Candida, chitin and chitinase capacity, and stool inflammation markers like calprotectin. Interpreted over time and paired with your symptom timeline, a Malassezia readout helps translate the fungal side of your microbiome into clear, evidence-guided steps for digestive comfort and long-term gut health.
Frequently Asked Questions
References
- Jovel J, Patterson J, Wang W, Hotte N, O'Keefe S, Mitchel T, Perry T, Kao D, Mason AL, Madsen KL, Wong, G. K.-S. (2016). Characterization of the gut microbiome using 16S or shotgun metagenomics. *Frontiers in Microbiology*, *7*, 459. https://doi.org/10.3389/fmicb.2016.00459
- Kapitan M, Niemiec MJ, Steimle A, Frick JS, Jacobsen ID (2019). Fungi as part of the microbiota and interactions with intestinal bacteria. *Current Topics in Microbiology and Immunology*, *422*, 265–301. https://doi.org/10.1007/82_2018_117
- Limon JJ, Tang J, Li D, Wolf AJ, Michelsen KS, Funari V, Gargus M, Nguyen C, Sharma P, Maymi VI, Iliev ID, Skalski JH, Brown J, Landers C, Borneman J, Braun J, Targan SR, McGovern DPB, Underhill DM (2019). Malassezia is associated with Crohn's disease and exacerbates colitis in mouse models. *Cell Host & Microbe*, *25*(3), 377–388.e6. https://doi.org/10.1016/j.chom.2019.01.007
- Hill JH, Round JL (2024). Intestinal fungal-host interactions in promoting and maintaining health. *Cell Host & Microbe*, *32*(10), 1668–1680. https://doi.org/10.1016/j.chom.2024.09.010
- Zhou X, Zhang X, Yu J (2024). Gut mycobiome in metabolic diseases: Mechanisms and clinical implication. *Biomedical Journal*, *47*(3), 100625. https://doi.org/10.1016/j.bj.2023.100625


















